Remove Disease Remove Events Remove PET Scan
article thumbnail

PET predicts adverse events in heart disease patients

AuntMinnie

PET imaging with nitrogen-13 (N-13) ammonia radiotracer can help predict major adverse cardiac events in patients with ischemic heart disease (IHD), according to a study published May 30 in Radiology: Cardiothoracic Imaging. Patients underwent the scans between January 2017 and January 2021.

Disease 110
article thumbnail

Study validates diagnostic tool for identifying amyloid beta plaques, the hallmark of Alzheimer's disease

Medical Xpress: Radiology

Amyloid PET scans provide in-vivo evidence of Alzheimer's disease (AD) pathology. A special form of electroencephalograms (a test that measures electrical activity in the brain) referred to as event-related potentials (ERPs), measures electrical activity that reflects both sensory and cognitive responses to stimuli.

Disease 60
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Recurrent Brain Trauma May Increase Alzheimer’s Risk

Imaging Technology

milla1cf Mon, 05/22/2023 - 13:16 May 22, 2023 — New research finds that the brains of otherwise healthy military personnel who are exposed to explosions show an abnormal brain accumulation of amyloid-beta protein—a protein that plays a role in the development of Alzheimer’s disease.

Disease 122
article thumbnail

Meet the Minnies 2024 semifinal candidates

AuntMinnie

tesla MRI AI body composition analysis Cardiac PET Cryo/thermoablation CT colonography Genicular artery embolization Hyperpolarized xenon-129 MRI PET/MRI Photon-counting CT Radiomics Theranostics Whole-body MRI screening Image of the Year 3D PET/MR image. PET scans predict patient response to Pluvicto.

article thumbnail

GE HealthCare Receives FDA Clearance of a New Deep Learning Solution for Enhanced Image Quality in PET/CT, Advancing its Leadership Position in AI

Imaging Technology

We can’t treat what we don’t see, which is why we require precise image quality to help diagnose, plan treatment for, and monitor disease,” explains Prof. Medical imaging is a crucial tool for diagnosing disease, identifying a course of treatment, and determining whether therapy is successful for millions of patients around the world.

article thumbnail

Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer

Imaging Technology

For example, results showed that among the subgroup (n=76) of patients in the Evaluable PET Scan Population who had undergone primary treatment with radiation therapy for prostate cancer, the overall patient-level DR was 99% (75/76) and consistently high across the three independent readers (range 93-99%).

article thumbnail

U.S. FDA Approves Blue Earth Diagnostics’ POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

Imaging Technology

This event marks a major milestone in the expansion of Blue Earth Diagnostics’ robust prostate cancer portfolio. It is labeled with the radioisotope fluorine-18 (18F) to enable PET imaging of the prostate and other areas of the body where prostate cancer may have spread. Gauden , D.Phil., The adverse reactions reported in ≥0.4%